Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06487247
NA

HEME Home Transfusion Program

Sponsor: Dana-Farber Cancer Institute

View on ClinicalTrials.gov

Summary

This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quality of life, mood, and end-of-life health care utilization for patients with hematologic malignancies.

Official title: Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

700

Start Date

2025-09-10

Completion Date

2029-05-31

Last Updated

2025-09-17

Healthy Volunteers

No

Interventions

BEHAVIORAL

HEME-Hospice Program

A care delivery program that combines home-based transfusions with routine home hospice care. Transfusions are administered by trained transfusion nurses. Standard hospice care is provided by an interdisciplinary team of non-transfusion nurse case managers, hospice aides, social workers, and chaplains.

Locations (2)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States